Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | OGA | O60502 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5356245 | 0.84 | OGA (0.43) | FGF1G6PDOGACA2CA1 | |
| SCHEMBL25432282 | 0.81 | CYP3A4 (0.31) | — | |
| SCHEMBL16392960 | 0.77 | THRB (0.46) | CYP2D6THRBHSD17B10CA2P4HB | |
| SCHEMBL5973361 | 0.77 | THRB (0.46) | CYP2D6THRBHSD17B10CA2P4HB | |
| SCHEMBL25346209 | 0.77 | THRB (0.46) | CYP2D6THRBHSD17B10CA2P4HB | |
| SCHEMBL18349742 | 0.76 | THRB (0.42) | CYP2D6THRBHSD17B10CA2P4HB | |
| SCHEMBL5973544 | 0.76 | THRB (0.45) | CYP2D6THRBHSD17B10CA2P4HB | |
| SCHEMBL10291154 | 0.74 | PRKD3 (0.43) | CYP2D6G6PDTHRBHSD17B10CA2 | |
| SCHEMBL12038195 | 0.73 | PRKD3 (0.46) | CYP2D6G6PDTHRBHSD17B10CA2 | |
| SCHEMBL14175697 | 0.73 | PRKD3 (0.46) | CYP2D6G6PDTHRBHSD17B10CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7230096-B2 | Inhibitors against galectins | FORSKARPATENT I SYD AB (SE) | 2007-06-12 | — | — | US | disclosed |
| US-20040147730-A1 | Inhibitors against galectins | FORSKARPATENT I SYD AB (SE) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147730-A1 | Inhibitors against galectins | LGALS1, LGALS3, LGALS2 | FGF1 3160/4885CYP2D6 4096/4885G6PD 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.